What is the address of BELGIAN INFUSIONS?

The registered office of BELGIAN INFUSIONS is located at Chemin de la Longue Borne 27, 7060 Soignies.

Is BELGIAN INFUSIONS still active?

Yes. According to the CBE (29 October 2026) BELGIAN INFUSIONS is active, legal situation “Normale toestand”, started on 14 December 2020.

Is BELGIAN INFUSIONS registered on Peppol?

Yes, BELGIAN INFUSIONS is registered on the Peppol network with ID 0208:0759731813.

What is the enterprise number of BELGIAN INFUSIONS?

The enterprise number of BELGIAN INFUSIONS is BE0759731813.

When was BELGIAN INFUSIONS founded?

BELGIAN INFUSIONS was founded on 14 December 2020.

Who are the directors of BELGIAN INFUSIONS?

According to the 2025 annual accounts, the directors of BELGIAN INFUSIONS are: Philippe LEFEBVRE.

Is BELGIAN INFUSIONS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 December 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did BELGIAN INFUSIONS make in 2025?

BELGIAN INFUSIONS posted a profit after taxes of € 376,510 in financial year 2025.

What is the revenue of BELGIAN INFUSIONS?

As a small company, BELGIAN INFUSIONS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 586,104.

Does BELGIAN INFUSIONS have a website?

Yes, BELGIAN INFUSIONS has a website at belgian-infusions.be.

BELGIAN INFUSIONS (Private Limited) - Soignies

Q: What does BELGIAN INFUSIONS do?

BELGIAN INFUSIONS is registered with the CBE as active in: Vervaardiging van andere chemische producten, neg. Private Limited, started on 14 December 2020, 1 establishment.

Dossier BELGIAN INFUSIONS, printed on 29 October 2026 from databakkes.be/en/0759731813/belgian-infusions. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

BELGIAN INFUSIONS from Soignies, company number BE0759731813, closed financial year 2025 with a result of € 376,510 after tax. For that financial year BELGIAN INFUSIONS recorded a gross margin of € 586,104 and equity of € 629,711. Compared with financial year 2024, the result moved from € 90,247 to € 376,510. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 629,711

▲ 210% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 376,510

▲ € 286,263 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 14,161

▼ 78% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 576,437.

People and assets in 2025

Vehicles and equipment

€ 615,302

▼ 4% vs 2024

Of which on lease € 606,653.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 508,313

▼ 1% vs 2024

€ 41,375 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 174,291

▼ 58% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 46,276

▲ 24% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 63,637 Gross margin 2022: € 63,637 First fiscal year in the series	€ 104,219 Gross margin 2023: € 104,219 ▲ 64% vs 2022 (€ 63,637) Favourable step	€ 204,031 Gross margin 2024: € 204,031 ▲ 96% vs 2023 (€ 104,219) Favourable step	€ 586,104 Gross margin 2025: € 586,104 ▲ 187% vs 2024 (€ 204,031) Favourable step	▲ 187%
Profit after taxes	€ 32,853 Profit after taxes 2022: € 32,853 First fiscal year in the series	€ 58,696 Profit after taxes 2023: € 58,696 ▲ 79% vs 2022 (€ 32,853) Favourable step	€ 90,247 Profit after taxes 2024: € 90,247 ▲ 54% vs 2023 (€ 58,696) Favourable step	€ 376,510 Profit after taxes 2025: € 376,510 ▲ € 286,263 vs 2024 (€ 90,247) Favourable step	▲ € 286,263
Equity	€ 53,983 Equity 2022: € 53,983 First fiscal year in the series	€ 112,679 Equity 2023: € 112,679 ▲ 109% vs 2022 (€ 53,983) Favourable step	€ 202,927 Equity 2024: € 202,927 ▲ 80% vs 2023 (€ 112,679) Favourable step	€ 629,711 Equity 2025: € 629,711 ▲ 210% vs 2024 (€ 202,927) Favourable step	▲ 210%
Total debts	€ 150,597 Total debts 2022: € 150,597 First fiscal year in the series	€ 795,234 Total debts 2023: € 795,234 ▲ € 644,637 vs 2022 (€ 150,597) Unfavourable step	€ 1,143,188 Total debts 2024: € 1,143,188 ▲ 44% vs 2023 (€ 795,234) Unfavourable step	€ 881,887 Total debts 2025: € 881,887 ▼ 23% vs 2024 (€ 1,143,188) Favourable step	▼ 23%
Cash	€ 33,255 Cash 2022: € 33,255 First fiscal year in the series	€ 15,073 Cash 2023: € 15,073 ▼ 55% vs 2022 (€ 33,255) Unfavourable step	€ 63,820 Cash 2024: € 63,820 ▲ € 48,747 vs 2023 (€ 15,073) Favourable step	€ 14,161 Cash 2025: € 14,161 ▼ 78% vs 2024 (€ 63,820) Unfavourable step	▼ 78%
Land & buildings	€ 122,220 Land & buildings 2022: € 122,220 First fiscal year in the series	€ 148,756 Land & buildings 2023: € 148,756 ▲ 22% vs 2022 (€ 122,220) Unchanged	€ 165,527 Land & buildings 2024: € 165,527 ▲ 11% vs 2023 (€ 148,756) Unchanged	€ 503,312 Land & buildings 2025: € 503,312 ▲ 204% vs 2024 (€ 165,527) Unchanged	▲ 204%
Retained profit	€ 50,983 Retained profit 2022: € 50,983 First fiscal year in the series	€ 109,679 Retained profit 2023: € 109,679 ▲ 115% vs 2022 (€ 50,983) Favourable step	€ 199,927 Retained profit 2024: € 199,927 ▲ 82% vs 2023 (€ 109,679) Favourable step	€ 576,437 Retained profit 2025: € 576,437 ▲ 188% vs 2024 (€ 199,927) Favourable step	▲ 188%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 491,051 Bank debt 2023: € 491,051 Unchanged (€ 0) Unfavourable step	€ 511,374 Bank debt 2024: € 511,374 ▲ 4% vs 2023 (€ 491,051) Unfavourable step	€ 508,313 Bank debt 2025: € 508,313 ▼ 1% vs 2024 (€ 511,374) Favourable step	▼ 1%
Balance sheet total	€ 204,580 Balance sheet total 2022: € 204,580 First fiscal year in the series	€ 907,913 Balance sheet total 2023: € 907,913 ▲ € 703,333 vs 2022 (€ 204,580) Unchanged	€ 1,346,115 Balance sheet total 2024: € 1,346,115 ▲ 48% vs 2023 (€ 907,913) Unchanged	€ 1,528,356 Balance sheet total 2025: € 1,528,356 ▲ 14% vs 2024 (€ 1,346,115) Unchanged	▲ 14%

Key figures of BELGIAN INFUSIONS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BELGIAN INFUSIONS?

What happened at BELGIAN INFUSIONS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 376,510 (▲ € 286,263 vs 2024). filed late Source: NBB ↗
Sep 1, 2021 New establishment in Soignies. KBO
2020 Philippe LEFEBVRE became a director. NBB
Dec 14, 2020 Start of the company according to the CBE. KBO

In short

From € 32,853 profit in 2022 to € 376,510 profit in 2025.

Paid € 190,482 in corporate taxes since 2022.

Best year ever: 2025, with € 376,510 profit.

Original PDFs at the National Bank ↗

Management

Philippe LEFEBVRE

BELGIAN INFUSIONS

Behind BELGIAN INFUSIONS is Philippe LEFEBVRE.

Directors

According to the 2025 annual accounts

Philippe LEFEBVRE

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin de la Longue Borne 27

7060 Soignies

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ACVM

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTP belgian-infusions.be

Canonical: https://www.belgian-infusions.be/

Technologies

Font AwesomeGoogle FontsNginxWPML

Hosting & Email

Email provider

Microsoft 365

Hosting

OVH, FR

DNS

OVH DNS

Website info

HTTPS Nee

Languages EN, FR

Features

Blog Client portal Contact page

Security

✗ HTTPS

✓ SPF

✗ DMARC

Details

Company number

0759.731.813

VAT number

BE 0759.731.813

Registered office

Chemin de la Longue Borne 27, 7060 Soignies

Names & denominations

BELGIAN INFUSIONS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 December 2020

Peppol

Active · Active since 9 Dec 2024

Contact

belgian-infusions.be

Activities · NACE

Vervaardiging van andere chemische producten, neg

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Handelsbemiddeling in de groothandel in andere specifieke goederen

Vervaardiging van andere voedingsmiddelen, neg

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Handelsbemiddeling in de niet-gespecialiseerde groothandel

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

BELGIAN INFUSIONS

Warning lights

Financials

What happened to BELGIAN INFUSIONS?

Management

Directors

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions